MASHINIi

Turnstone Biologics Corp..

TSBX.US | Research and experimental development on natural sciences and engineering

Turnstone Biologics Corp. is a clinical-stage biotechnology company focused on developing innovative cancer immunotherapies. The company's primary focus is on tumor-infiltrating lymphocyte (TIL) therapies and oncolytic virus (OV) immunotherapies. Their TIL programs involve selecting, expanding, and ...Show More

Ethical Profile

Mixed.

Turnstone Biologics Corp. (TSBX.US) presents a mixed ethical profile. The company is deeply committed to "Better Health for All," developing next-generation TIL therapies for solid tumors, addressing a significant unmet medical need. Its lead candidate, TIDAL-01, is in Phase 1 trials, with initial data showing a complete response in an MSS-CRC patient. Turnstone raised $80 million in its IPO to fund these trials, offers comprehensive access programs reaching over 80% of those in need, and prices products at 1.1-1.15x production cost. However, critics point to the company's animal testing practices for product safety, which means it is not on the Cruelty Free Investing list. Information on other ethical areas is limited.

Value Scores

Better Health for All60
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business-40
-100100
Kind to Animals-60
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

60

Turnstone Biologics Corp. is a clinical-stage biotechnology company entirely focused on developing innovative cancer immunotherapies, specifically TIL and oncolytic virus therapies, to address unmet medical needs in various solid tumor types.

1
This indicates that 100% of its principal goods and services are intended to deliver revolutionary health benefits. As the company is clinical-stage and not currently selling products, it generates no revenue from products with established negative health outcomes.
2
The company's R&D is entirely dedicated to developing these cancer immunotherapies, meaning 100% of its R&D budget is allocated to health improvement.
3
The company conducts Phase 1 clinical trials for TIDAL-01, with safety and tolerability as primary objectives, and has filed registration statements with the SEC that became effective on July 20, 2023, indicating adherence to regulatory standards for clinical trial conduct.
4

Fair Money & Economic Opportunity

0

No evidence available to assess Turnstone Biologics Corp. on Fair Money & Economic Opportunity.

Fair Pay & Worker Respect

0

No evidence available to assess Turnstone Biologics Corp. on Fair Pay & Worker Respect.

Fair Trade & Ethical Sourcing

0

No evidence available to assess Turnstone Biologics Corp. on Fair Trade & Ethical Sourcing.

Honest & Fair Business

-40

Turnstone Biologics maintains a confidential and anonymous financial concern hotline for complaints regarding accounting, internal accounting controls, or auditing matters, a facility required by the SEC.

1
However, there is no evidence provided regarding the existence of independent investigation processes for these reports, nor details on training, uptake, or resolution times.

Kind to Animals

-60

Turnstone Biologics Corp. is not listed as cruelty-free due to its animal testing practices, indicating that none of its products are certified cruelty-free.

1
The company conducts animal testing to assess product safety.
2
There is no information provided regarding the volume of animals used in testing or the extent of alternative testing methods employed, nor any specific policy for reducing or prohibiting animal testing.
3

No War, No Weapons

0

No evidence available to assess Turnstone Biologics Corp. on No War, No Weapons.

Planet-Friendly Business

0

No evidence available to assess Turnstone Biologics Corp. on Planet-Friendly Business.

Respect for Cultures & Communities

0

No evidence available to assess Turnstone Biologics Corp. on Respect for Cultures & Communities.

Safe & Smart Tech

0

No evidence available to assess Turnstone Biologics Corp. on Safe & Smart Tech.

Zero Waste & Sustainable Products

0

No evidence available to assess Turnstone Biologics Corp. on Zero Waste & Sustainable Products.

Own Turnstone Biologics Corp.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.